CeriBell, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
CeriBell, Inc. (CBLL) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$2.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-10
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$148.00K, a 108.49% decline year-over-year.
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.96M.
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $3.48M, a 76.84% increase year-over-year.
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $765.00K, a 60.28% decline year-over-year.
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $4.22M, a 71.04% increase from fiscal 2024.
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $2.47M, a 13.99% increase from fiscal 2023.
- CeriBell, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.17M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$148.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.10M 10-Q · filed 2026-08-10 | $1.37M derived: sum of 3 quarters · filed 2026-08-10 | $2.14M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$1.96M 10-Q · filed 2026-05-11 | $1.52M derived: sum of 2 quarters · filed 2026-05-11 | $2.28M derived: sum of 3 quarters · filed 2026-05-11 | $4.03M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.24M derived: sum of 2 quarters · filed 2026-02-24 | $5.98M derived: sum of 3 quarters · filed 2026-08-10 | $4.22M 10-K · filed 2026-02-24 |
| 2025-09-30 | $765.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.51M derived: sum of 2 quarters · filed 2026-08-10 | $748.00K 10-Q · filed 2025-11-04 | $2.71M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$17.00K 10-Q · filed 2026-08-10 | $1.95M derived: sum of 3 quarters · filed 2026-08-10 | $3.87M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$1.76M 10-Q · filed 2026-05-11 | $204.00K derived: sum of 2 quarters · filed 2026-05-11 | $2.13M derived: sum of 3 quarters · filed 2026-05-11 | $2.55M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.89M derived: sum of 2 quarters · filed 2026-02-24 | $4.31M derived: sum of 3 quarters · filed 2026-02-24 | $2.47M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.34M derived: sum of 2 quarters · filed 2025-11-04 | $504.00K 10-Q · filed 2025-11-04 | $2.58M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $418.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.42M 10-Q · filed 2025-08-05 | $659.00K derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | -$1.84M 10-Q · filed 2025-05-08 | $241.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.17M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $85.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |